PL59396B1 - - Google Patents
Download PDFInfo
- Publication number
- PL59396B1 PL59396B1 PL119096A PL11909667A PL59396B1 PL 59396 B1 PL59396 B1 PL 59396B1 PL 119096 A PL119096 A PL 119096A PL 11909667 A PL11909667 A PL 11909667A PL 59396 B1 PL59396 B1 PL 59396B1
- Authority
- PL
- Poland
- Prior art keywords
- inactivator
- kie
- crystals
- kallikrein
- solution
- Prior art date
Links
- 230000000937 inactivator Effects 0.000 claims description 25
- 102000001399 Kallikrein Human genes 0.000 claims description 17
- 108060005987 Kallikrein Proteins 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- 238000002425 crystallisation Methods 0.000 claims description 9
- 230000008025 crystallization Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 150000001450 anions Chemical class 0.000 claims description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 4
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- -1 hydroxide ions Chemical class 0.000 claims description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 2
- 239000013078 crystal Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012670 alkaline solution Substances 0.000 description 3
- 239000001166 ammonium sulphate Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229940088623 biologically active substance Drugs 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical group Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
- KNIUHBNRWZGIQQ-UHFFFAOYSA-N 7-diethoxyphosphinothioyloxy-4-methylchromen-2-one Chemical compound CC1=CC(=O)OC2=CC(OP(=S)(OCC)OCC)=CC=C21 KNIUHBNRWZGIQQ-UHFFFAOYSA-N 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 101000605527 Rattus norvegicus Kallikrein-1 Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 102000057032 Tissue Kallikreins Human genes 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052601 baryte Inorganic materials 0.000 description 1
- 239000010428 baryte Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL59396B1 true PL59396B1 (enExample) | 1969-12-29 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA88769C2 (uk) | Відновний агент для розчинного хромату, що міститься в цементі | |
| ES2256509T3 (es) | Metodo para la preparacion de acido lactico y dihidrato de sulfato de calcio. | |
| FI75571B (fi) | Framstaellningsfoerfarande foer synnerligen kristalliniskt natriumcefoperazon. | |
| US5847107A (en) | Method of preparing mixed glucosamine salts | |
| SE325369B (enExample) | ||
| Markowitz | A convenient method for preparation of quaternary ammonium salts | |
| NO951845D0 (no) | Fremgangsmåte for fremstilling av en höytetthets Cesium- og Rubidiumsaltopplösning | |
| ES2211389T3 (es) | Procedimiento para la obtencion de derivados de guanidina. | |
| NO961976L (no) | Fremgangsmåte for fremstilling av en cesium- og rubidiumsaltopplösning | |
| CN115322122A (zh) | 一种肌氨酸螯合钙水溶液制备一水肌酸的方法 | |
| US4124636A (en) | Method of preparing monopotassium L-malate and its monohydrate | |
| ES2220383T3 (es) | Composicion retardante para yeso. | |
| US4148753A (en) | Neutralization of phosphoric acid activated carbon | |
| GB1091345A (en) | Process for the preparation of pure ammonium phosphate | |
| CS276111B6 (en) | Process for separating barium from strontium salts being dissolved in water | |
| EP0461520A2 (en) | Oxetanocin G anhydride crystals and process for producing the same | |
| SU1234362A1 (ru) | Способ получени одноводного магнийаммонийфосфата | |
| RU2137775C1 (ru) | Способ выделения натриевой соли оксациллина | |
| CS231802B1 (cs) | Způsob čištění surové kyseliny lysergové | |
| SU860705A3 (ru) | Способ получени кристаллической формы D-конфигурации диаммониевой соли 7 - -карбокси- -( -оксифенил)ацетамидо/-7 -метокси-3-(1-метилтетразол-5-ил)-тиометил-1-оксадетиа-3-цефем-4-карбоновой кислоты | |
| Wengel et al. | Analogues of the antibiotic puromycin as potential prodrugs of 3′‐amino‐3′‐deoxythymidine | |
| NO169717B (no) | Fremgangsmaate for fremstilling av et stabilt hydrat av etpenicillinderivat. | |
| SU767028A1 (ru) | Способ получени сульфата кали | |
| JPH04261189A (ja) | トリフルオロメタンスルホン酸スズの製造法 | |
| US2668852A (en) | Neutral calcium 4-aminosalicylate hemihydrate and preparation of the same |